在使用回归模型的多药学背景下处理药物不良反应
Jakob Sommer1,2, Roberto Viviani3,4, Justyna Wozniak1
1Institute of Clinical Pharmacology, University Hospital of RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany.
Scientific reports
|November 9, 2024
概括
这项研究使用先进的回归模型来识别老年人服用多种药物的药物风险. 这些方法有助于检测严重药物不良反应 (ADRs),如跌倒和出血.
科学领域:
- 药物监督 药物监督 药物监督
- 生物统计学 生物统计学
- 老年医学 老年医学
背景情况:
- 在老年人中,多种药物显著增加了药物不良反应 (ADR) 的风险.
- 对罕见的ADR事件和药物组合进行高维度现实世界数据的分析带来了重大的统计挑战.
- 传统的统计方法难以应对多药房数据的复杂性.
研究的目的:
- 应用马和拉索回归模型来分析多药学中的罕见事件.
- 为了确定潜在的ADR相关药物,与严重的结果,如跌倒和出血相关.
- 改进在大型,稀疏的药监数据集中的信号检测.
主要方法:
- 在多中心数据集上使用马和拉索回归技术 (来自ADRED项目的7175个案例).
- 专注于检测100种最常见的药物与急诊室入院的严重副作用之间的关联.
- 使用50%和90%的可信度间隔进行分类的积极预测.
主要成果:
- 使用马或拉索先验的回归模型在分析复杂数据集中的ADR方面被证明是有效的.
- 这两种先验都产生了一致和临床上有意义的结果,增强了信号检测.
- 马回归发现了更少的潜在的积极预测因素,表明其作为诊断工具的实用性.
结论:
- 马和拉索回归是分析药物不良反应在多药学环境中的有效工具.
- 这些方法提供了一个全面的方法来管理大,稀疏的药监数据集.
- 需要进一步的研究来确定解释正回归结果的适当值.
相关概念视频
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49
Pharmacokinetic Models: Comparison and Selection Criterion
45
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
45
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
94
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
94
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60


